Ono Pharmaceutical Co., Ltd.
4528.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥59,328 | ¥127,977 | ¥143,532 | ¥105,025 |
| Dep. & Amort. | ¥26,894 | ¥18,140 | ¥17,451 | ¥17,721 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | ¥38,337 | -¥28,958 | ¥1,437 | -¥30,107 |
| Other Non-Cash | -¥42,100 | -¥6,499 | -¥2,810 | -¥30,810 |
| Operating Cash Flow | ¥82,459 | ¥110,660 | ¥159,610 | ¥61,829 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥5,431 | -¥4,020 | -¥14,497 | -¥12,277 |
| Net Acquisitions | -¥364,816 | ¥0 | -¥9,151 | -¥6,766 |
| Inv. Purchases | -¥4,075 | -¥36,731 | -¥140,591 | -¥58,613 |
| Inv. Sales/Matur. | ¥240,839 | ¥106,021 | ¥55,860 | ¥78,582 |
| Other Inv. Act. | -¥3,302 | -¥17,193 | ¥8,120 | ¥5,112 |
| Investing Cash Flow | -¥136,785 | ¥48,077 | -¥100,259 | ¥6,038 |
| Financing Activities | – | – | – | – |
| Debt Repay. | ¥135,000 | ¥0 | ¥0 | ¥0 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | -¥1 | -¥50,010 | -¥1 | -¥30,007 |
| Dividends Paid | -¥37,516 | -¥37,183 | -¥29,742 | -¥27,666 |
| Other Fin. Act. | -¥3,184 | -¥2,655 | -¥2,741 | -¥2,564 |
| Financing Cash Flow | ¥94,299 | -¥89,848 | -¥32,484 | -¥60,237 |
| Forex Effect | -¥1,548 | ¥1,116 | ¥155 | ¥436 |
| Net Chg. in Cash | ¥38,426 | ¥70,006 | ¥27,023 | ¥8,067 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥166,141 | ¥96,135 | ¥69,112 | ¥61,045 |
| End Cash | ¥204,567 | ¥166,141 | ¥96,135 | ¥69,112 |
| Free Cash Flow | ¥74,469 | ¥89,831 | ¥145,113 | ¥49,552 |